Jane Street Group, LLC Sage Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$30.71 - $45.71 $291,745 - $434,245	9,500 Added 74.8%	22,200 $735,000
Q4 2021 Feb 15, 2022	SELL	$37.06 - $47.11 $548,488 - $697,228	-14,800 Reduced 53.82%	12,700 $540,000
Q3 2021 Nov 16, 2021	SELL	$40.26 - $57.37 $7.38 Million - $10.5 Million	-183,300 Reduced 86.95%	27,500 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $10.3 Million - $14.8 Million	186,800 Added 778.33%	210,800 $12 Million
Q1 2021 May 18, 2021	SELL	$70.65 - $96.76 $2.31 Million - $3.16 Million	-32,700 Reduced 57.67%	24,000 $1.8 Million
Q4 2020 Feb 17, 2021	SELL	$58.41 - $89.06 $6.72 Million - $10.3 Million	-115,100 Reduced 67.0%	56,700 $4.91 Million
Q3 2020 Nov 17, 2020	BUY	$41.13 - $62.45 $2.15 Million - $3.26 Million	52,200 Added 43.65%	171,800 $10.5 Million
Q2 2020 Aug 17, 2020	BUY	$25.95 - $43.15 $2.86 Million - $4.76 Million	110,200 Added 1172.34%	119,600 $4.97 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $1.06 Million - $3.12 Million	-40,400 Reduced 81.12%	9,400 $270,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $2.73 Million - $7.03 Million	45,400 Added 1031.82%	49,800 $3.6 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $406,841 - $550,884	2,900 Added 193.33%	4,400 $617,000
Q2 2019 Aug 15, 2019	SELL	$157.85 - $183.09 $142,065 - $164,781	-900 Reduced 37.5%	1,500 $275,000
Q1 2019 May 16, 2019	SELL	$89.33 - $163.65 $62,531 - $114,555	-700 Reduced 22.58%	2,400 $382,000
Q4 2018 Feb 15, 2019	BUY	$81.94 - $139.71 $254,014 - $433,101	3,100 New	3,100 $297,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.